Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03974126
Other study ID # Dnr 2018/968
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 30, 2019
Est. completion date November 15, 2019

Study information

Verified date January 2020
Source Lund University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Individuals with low copy numbers of salivary amylase gene have lower salivary amylase levels and might therefore have decreased capacity to metabolize starch into glucose. We will in a randomized crossover meal study examine the postprandial response of high-starch meals in individuals with either low or high copy number of the salivary amylase gene.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date November 15, 2019
Est. primary completion date September 19, 2019
Accepts healthy volunteers No
Gender All
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria:

- Participant in the Malmö Offspring Study

- Genotyped for AMY1 copy number variation and selected for having either low (2-4) or high (10 or above) copy number of AMY1

- Gender: both males and females

- Completed information on dietary habits

Exclusion Criteria:

- Allergic to wheat, gluten intolerant or on a low-carbohydrate diet

- Inability to eat up to 4 slices of white bread in 15 minutes

- Use of medication known to influence glucose metabolism, appetite or saliva flow

- Diagnosed diabetes or high fasting plasma glucose (above 6.1 mmol/L)

- Smoking

Study Design


Related Conditions & MeSH terms

  • Postprandial Glucose and Insulin Response

Intervention

Other:
40 grams of starch
40 grams of starch in form of white bread to be consumed within 15 minutes
80 grams of starch
80 grams of starch in form of white bread to be consumed within 15 minutes

Locations

Country Name City State
Sweden Lund University Lund

Sponsors (2)

Lead Sponsor Collaborator
Lund University University of Copenhagen

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other weight weight will be measured 0 minutes
Primary Postprandial glucose Postprandial glucose concentration assessed as incremental area under curve over 120 minutes (0, 7, 15, 30, 45, 60 ,90, 120 minutes) AUC (0, 7, 15, 30, 45, 60, 90, 120 minutes)
Primary Postprandial insulin postprandial insulin concentration assessed as incremental area under curve over 120 minutes (0, 7, 15, 30, 45, 60 ,90, 120 minutes) AUC (0, 7, 15, 30, 45, 60, 90, 120 minutes)
Primary Preabsorptive insulin release Insulin concentration at 7 minutes 7 minutes
Secondary subjective satiety Visual analog scales (VAS) to evaluate hunger and satiety 0, 15, 30, 45, 60, 90, 120 minutes
Secondary salivary amylase activity Salivary amylase activity will be measured by ELISA kits 0 minutes